Murine neonatal cardiac regeneration depends on Insulin-like growth factor 1 receptor signaling
Unlike adult mammals, the hearts of neonatal mice possess the ability to completely regenerate from myocardial infarction (MI). This observation has sparked vast interest in deciphering the potentially lifesaving and morbidity-reducing mechanisms involved in neonatal cardiac regeneration. In mice, the regenerative potential is lost within the first week of life and coincides with a reduction of Insulin-like growth factor 1 receptor (Igf1r) expression in the heart. Igf1r is a well-known regulator of cardiomyocyte maturation and proliferation in neonatal mice. To test the role of Igf1r as a pivotal factor in cardiac regeneration, we knocked down (KD) Igf1r specifically in cardiomyocytes using recombinant adeno-associated virus (rAAV) delivery and troponin T promotor driven shRNAmirs. Cardiomyocyte specific Igf1r KD versus control mice were subjected to experimental MI by permanent ligation of the left anterior descending artery (LAD). Cardiac functional and morphological data were analyzed over a 21-day period. Neonatal Igf1r KD mice showed reduced systolic cardiac function and increased fibrotic cardiac remodeling 21 days post injury. This cardiac phenotype was associated with reduced cardiomyocyte nuclei mitosis and decreased AKT and ERK phosphorylation in Igf1r KD, compared to control neonatal mouse hearts. Our in vivo murine data show that Igf1r KD shifts neonatal cardiac regeneration to a more adult-like scarring phenotype, identifying cardiomyocyte-specific Igf1r signaling as a crucial component of neonatal cardiac regeneration.
Authors
- Erika Hilbold (ORCID: https://orcid.org/0000-0001-9808-3729)
- Axel Bauer (ORCID: https://orcid.org/0000-0001-9201-8555)
- Bernhard J. Haubner (ORCID: https://orcid.org/0000-0003-1766-8720)
- Frank Thomas Ruschitzka (ORCID: https://orcid.org/0000-0001-5972-0596)
- Thomas Schuetz
- Josef Penninger (ORCID: https://orcid.org/0000-0002-8194-3777)
- Alexander Bild
- Eva Beck
- Christian Bär (ORCID: https://orcid.org/0000-0001-9276-9383)
- Theresa Dolejsi (ORCID: https://orcid.org/0000-0002-1356-2171)
- Johannes Zuber (ORCID: https://orcid.org/0000-0001-8810-6835)
- Fabio Fugger
- Jasmina Gavranovic-Novakovic
- Thomas Hoffmann (ORCID: https://orcid.org/0000-0002-1589-0013)
- M. Duin
Institutions
- Institute of Molecular Biotechnology (AT)
- Austrian Academy of Sciences (AT)
- University of British Columbia (CA)
- Innsbruck Medical University (AT)
- Research Institute of Molecular Pathology (AT)
- University of Zurich (CH)
- Medizinische Hochschule Hannover (DE)
- University Hospital of Zurich (CH)
- Fraunhofer Institute for Toxicology and Experimental Medicine (DE)
- Helmholtz Centre for Infection Research (DE)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1038/s41598-024-72783-4
- Citations
- 5
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Fondation Leducq
- Österreichischen Akademie der Wissenschaften
- Bundesministerium für Bildung und Forschung
- Austrian Science Fund
- Universität Wien
- Medizinische Universität Wien
- Medizinische Universität Innsbruck
- Österreichische Kardiologische Gesellschaft
- European Research Area Network on Cardiovascular Diseases
- T. Von Zastrow Foundation